Oxygenta Pharmaceutical Ltd Announces Board Meeting to Review Q1 Financials and Limited Review Report
Oxygenta Pharmaceutical Ltd has scheduled a Board Meeting on Saturday, July 25, 2026. The meeting is set at the company's corporate office and is intended to review key operational and financial aspects of the business.The agenda items for the board include the un-audited financial results corresponding to the quarter that ended June 30, 2026. Additionally, the meeting will focus on the Limited Review Report prepared for the same quarter. The board members will also address any other business as permitted by the Chair.
Stock Price Movement
Oxygenta Pharmaceutical Ltd shares settled at ₹49.98 today, climbing 2.21% as trading wrapped up this Wednesday. The stock maintained strong movement through the day, holding within an intraday range established by a low of ₹49.00 and a peak of ₹49.98.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.